AAAAAA

   
Results: 1-10 |
Results: 10
HYDROXYPROPYL CYCLODEXTRINS - POTENTIAL SYNERGISM WITH CARCINOGENS - COMMENTARY
Authors: VANCAUTEREN H JACQMIN P COUSSEMENT W MEULDERMANS W LAMPO A LAMMENS L
Citation: H. Vancauteren et al., HYDROXYPROPYL CYCLODEXTRINS - POTENTIAL SYNERGISM WITH CARCINOGENS - COMMENTARY, Journal of pharmaceutical sciences, 86(3), 1997, pp. 402-403
LOCATION OF THE HYDROXYL FUNCTIONS IN HYDROXYLATED METABOLITES OF NEBIVOLOL IN DIFFERENT ANIMAL SPECIES AND HUMAN-SUBJECTS AS DETERMINED BYONLINE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DIODE-ARRAY DETECTION
Authors: HENDRICKX J BOCKX M ZWIJSEN C BORGMANS C MANNENS G MEULDERMANS W HEYKANTS J
Citation: J. Hendrickx et al., LOCATION OF THE HYDROXYL FUNCTIONS IN HYDROXYLATED METABOLITES OF NEBIVOLOL IN DIFFERENT ANIMAL SPECIES AND HUMAN-SUBJECTS AS DETERMINED BYONLINE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DIODE-ARRAY DETECTION, Journal of chromatography, 729(1-2), 1996, pp. 341-354
THE PHARMACOKINETIC PROPERTIES OF TOPICAL LEVOCABASTINE - A REVIEW
Authors: HEYKANTS J VANPEER A VANDEVELDE V SNOECK E MEULDERMANS W WOESTENBORGHS R
Citation: J. Heykants et al., THE PHARMACOKINETIC PROPERTIES OF TOPICAL LEVOCABASTINE - A REVIEW, Clinical pharmacokinetics, 29(4), 1995, pp. 221-230
REDUCTION OF THE PRODRUG LOPERAMIDE OXIDE TO ITS ACTIVE-DRUG LOPERAMIDE IN THE GUT OF RATS, DOGS, AND HUMANS
Authors: LAVRIJSEN K VANDYCK D VANHOUDT J HENDRICKX J MONBALIU J WOESTENBORGHS R MEULDERMANS W HEYKANTS J
Citation: K. Lavrijsen et al., REDUCTION OF THE PRODRUG LOPERAMIDE OXIDE TO ITS ACTIVE-DRUG LOPERAMIDE IN THE GUT OF RATS, DOGS, AND HUMANS, Drug metabolism and disposition, 23(3), 1995, pp. 354-362
PLASMA-PROTEIN BINDING OF RISPERIDONE AND ITS DISTRIBUTION IN BLOOD
Authors: MANNENS G MEULDERMANS W SNOECK E HEYKANTS J
Citation: G. Mannens et al., PLASMA-PROTEIN BINDING OF RISPERIDONE AND ITS DISTRIBUTION IN BLOOD, Psychopharmacology, 114(4), 1994, pp. 566-572
THE PHARMACOKINETICS OF RISPERIDONE IN HUMANS - A SUMMARY
Authors: HEYKANTS J HUANG ML MANNENS G MEULDERMANS W SNOECK E VANBEIJSTERVELDT L VANPEER A WOESTENBORGHS R
Citation: J. Heykants et al., THE PHARMACOKINETICS OF RISPERIDONE IN HUMANS - A SUMMARY, The Journal of clinical psychiatry, 55, 1994, pp. 13-17
THE METABOLISM AND EXCRETION OF RISPERIDONE AFTER ORAL-ADMINISTRATIONIN RATS AND DOGS
Authors: MEULDERMANS W HENDRICKX J MANNENS G LAVRIJSEN K JANSSEN C BRACKE J LEJEUNE L LAUWERS W HEYKANTS J
Citation: W. Meuldermans et al., THE METABOLISM AND EXCRETION OF RISPERIDONE AFTER ORAL-ADMINISTRATIONIN RATS AND DOGS, Drug metabolism and disposition, 22(1), 1994, pp. 129-138
THE METABOLIC CONVERSION OF THE PRO-DRUG LOPERAMIDE OXIDE TO LOPERAMIDE IN-VITRO AND IN-VIVO
Authors: LAVRIJSEN K MONBALIU J VANBEIJSTERVELDT L WOESTENBORGHS R MEULDERMANS W VERLINDEN M HEYKANTS J
Citation: K. Lavrijsen et al., THE METABOLIC CONVERSION OF THE PRO-DRUG LOPERAMIDE OXIDE TO LOPERAMIDE IN-VITRO AND IN-VIVO, Gastroenterology, 106(4), 1994, pp. 10000246-10000246
ABSORPTION, METABOLISM, AND EXCRETION OF RISPERIDONE IN HUMANS
Authors: MANNENS G HUANG ML MEULDERMANS W HENDRICKX J WOESTENBORGHS R HEYKANTS J
Citation: G. Mannens et al., ABSORPTION, METABOLISM, AND EXCRETION OF RISPERIDONE IN HUMANS, Drug metabolism and disposition, 21(6), 1993, pp. 1134-1141
A PREDICTIVE MODEL FOR SUBSTRATES OF CYTOCHROME P450-DEBRISOQUINE (2D6)
Authors: KOYMANS L VERMEULEN NPE VANACKER SABE TEKOPPELE JM HEYKANTS JJP LAVRIJSEN K MEULDERMANS W DENKELDER GMD
Citation: L. Koymans et al., A PREDICTIVE MODEL FOR SUBSTRATES OF CYTOCHROME P450-DEBRISOQUINE (2D6), Chemical research in toxicology, 5(2), 1992, pp. 211-219
Risultati: 1-10 |